id | C00002893 |
---|---|
Name | Oxyresveratrol / 2,3,4,5'-Tetrahydroxystilbene |
CAS RN | 29700-22-9 |
Standard InChI | InChI=1S/C14H12O4/c15-11-4-3-10(14(18)8-11)2-1-9-5-12(16)7-13(17)6-9/h1-8,15-18H/b2-1+ |
Standard InChI (Main Layer) | InChI=1S/C14H12O4/c15-11-4-3-10(14(18)8-11)2-1-9-5-12(16)7-13(17)6-9/h1-8,15-18H |
Phytochemical cluster | No. 13 |
---|---|
KCF-S cluster | No. 295 |
By standard InChI | CHEMBL43065 |
---|---|
By standard InChI Main Layer | CHEMBL43065 |
By LinkDB | C10273 |
---|
By CAS RN |
---|
class name | count |
---|---|
rosids | 16 |
Liliopsida | 2 |
family name | count |
---|---|
Moraceae | 15 |
Melanthiaceae | 2 |
Fabaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL43065 |
CHEMBL1738132
(1)
|
7 / 44 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL43065 |
CHEMBL1020816
(1)
|
0 / 3 |
P39900 | Macrophage metalloelastase | M10A | CHEMBL43065 |
CHEMBL2051216
(1)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL43065 |
CHEMBL2051215
(1)
|
2 / 2 |
P37840 | Alpha-synuclein | Unclassified protein | CHEMBL43065 |
CHEMBL2354282
(1)
|
4 / 2 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | CHEMBL43065 |
CHEMBL664422
(1)
|
0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL43065 |
CHEMBL1020815
(1)
|
0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | CHEMBL43065 |
CHEMBL1794495
(1)
|
2 / 2 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | CHEMBL43065 |
CHEMBL2114807
(1)
|
4 / 2 |
P03956 | Interstitial collagenase | M10A | CHEMBL43065 |
CHEMBL2051212
(1)
|
0 / 1 |
P14679 | Tyrosinase | Oxidoreductase | CHEMBL43065 |
CHEMBL854612
(1)
CHEMBL854613
(1)
|
4 / 2 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | CHEMBL43065 |
CHEMBL663710
(1)
|
4 / 4 |
P45452 | Collagenase 3 | M10A | CHEMBL43065 |
CHEMBL2051217
(1)
|
1 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL43065 |
CHEMBL663698
(1)
|
0 / 0 |
P08253 | 72 kDa type IV collagenase | M10A | CHEMBL43065 |
CHEMBL2051213
(1)
CHEMBL2051219
(1)
|
1 / 3 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL43065 |
CHEMBL1738588
(1)
CHEMBL1738317
(1)
|
0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | CHEMBL43065 |
CHEMBL1737991
(1)
|
0 / 0 |
P08254 | Stromelysin-1 | M10A | CHEMBL43065 |
CHEMBL2051214
(1)
|
1 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL43065 |
CHEMBL2354311
(1)
|
1 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | CHEMBL43065 |
CHEMBL2354287
(1)
|
1 / 1 |
OMIM | preferred title | UniProt |
---|---|---|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#133239 | Esophageal cancer |
P04637
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#211980 | Lung cancer |
P04637
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P37840
|
#604229 | Peters anomaly |
Q16678
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
KEGG | disease name | UniProt |
---|---|---|
H00028 | Choriocarcinoma |
P03956
(related)
P04637 (related) P08253 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
|
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
|
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
P35354 (related) |
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
Q13148
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|